showed that targeting HIV-1 entry receptor gp120 with antibodies 2G12, b12, VRC01, VRC03 and targeting HIV-1 fusion receptor gp41 with antibodies 2F5 and 4E10 blocked HIV-1 trans-infection (17). The gene discussed is ITIH4; the disease is infection.